Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the study page document.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows Revision: v3.6.6 replacing v3.6.5, indicating a new build of the page. This appears to be a software update rather than a change to study information.SummaryDifference0.0%

- Check22 days agoChange DetectedAn NIH grant/contract entry for 2018 was added to the study's identifiers section. This clarifies the funding source associated with the trial and enhances transparency of sponsorship.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now displays Revision: v3.6.5 in place of v3.6.4, indicating a version update for the page. This appears to be a maintenance update rather than a change to study content.SummaryDifference0.0%

- Check51 days agoChange DetectedFooter now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a site version update. The change does not modify study information or other visible content.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3 on the page. This reflects a metadata/version update rather than a substantive change to study details.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.